The University of Alabama at Birmingham — Birmingham, Alabama

Public research footprint of The University of Alabama at Birmingham, compiled from the ClinicalTrials.gov public registry.

193

Registered studies

Active

Recruiting now

104

Completed

Stopped or withdrawn

Most-studied conditions

Non-muscle Invasive Bladder Cancer With Carcinoma in Situ · NSCLC (Non-small Cell Lung Cancer) · Advanced or Metastatic Solid Tumors · HER2-positive Breast Cancer

Recently updated registry entries

NCT05724199 — A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical… (Completed)
NCT06353256 — A Community Health Worker Intervention to Address Adverse Pregnancy Outcomes (Completed)
NCT07005232 — Lead Evaluation for Defibrillation and Reliability Post Approval Study (Enrolling By Invitation)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The University of Alabama at Birmingham?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.